LifeMD Statistics
Total Valuation
LifeMD has a market cap or net worth of $326.71 million. The enterprise value is $312.53 million.
Important Dates
The last earnings date was Tuesday, August 5, 2025, after market close.
| Earnings Date | Aug 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
LifeMD has 47.42 million shares outstanding. The number of shares has increased by 13.19% in one year.
| Current Share Class | 47.42M |
| Shares Outstanding | 47.42M |
| Shares Change (YoY) | +13.19% |
| Shares Change (QoQ) | -2.59% |
| Owned by Insiders (%) | 14.32% |
| Owned by Institutions (%) | 39.81% |
| Float | 38.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.21 |
| Forward PS | 1.12 |
| PB Ratio | 854.40 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 18.26 |
| P/OCF Ratio | 16.77 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.27 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 17.47 |
Financial Position
The company has a current ratio of 0.77, with a Debt / Equity ratio of 57.67.
| Current Ratio | 0.77 |
| Quick Ratio | 0.69 |
| Debt / Equity | 57.67 |
| Debt / EBITDA | 18.50 |
| Debt / FCF | 1.23 |
| Interest Coverage | -0.83 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -1.85% |
| Return on Invested Capital (ROIC) | -6.17% |
| Return on Capital Employed (ROCE) | -20.25% |
| Revenue Per Employee | $799,882 |
| Profits Per Employee | -$29,427 |
| Employee Count | 307 |
| Asset Turnover | 3.57 |
| Inventory Turnover | 11.49 |
Taxes
In the past 12 months, LifeMD has paid $402,000 in taxes.
| Income Tax | 402,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +26.19% in the last 52 weeks. The beta is 1.72, so LifeMD's price volatility has been higher than the market average.
| Beta (5Y) | 1.72 |
| 52-Week Price Change | +26.19% |
| 50-Day Moving Average | 11.46 |
| 200-Day Moving Average | 7.52 |
| Relative Strength Index (RSI) | 32.40 |
| Average Volume (20 Days) | 2,544,498 |
Short Selling Information
The latest short interest is 4.43 million, so 9.33% of the outstanding shares have been sold short.
| Short Interest | 4.43M |
| Short Previous Month | 4.34M |
| Short % of Shares Out | 9.33% |
| Short % of Float | 11.37% |
| Short Ratio (days to cover) | 4.19 |
Income Statement
In the last 12 months, LifeMD had revenue of $245.56 million and -$9.03 million in losses. Loss per share was -$0.21.
| Revenue | 245.56M |
| Gross Profit | 215.05M |
| Operating Income | -2.03M |
| Pretax Income | -23.07M |
| Net Income | -9.03M |
| EBITDA | -371,025 |
| EBIT | -2.03M |
| Loss Per Share | -$0.21 |
Full Income StatementBalance Sheet
The company has $36.23 million in cash and $22.05 million in debt, giving a net cash position of $14.18 million or $0.30 per share.
| Cash & Cash Equivalents | 36.23M |
| Total Debt | 22.05M |
| Net Cash | 14.18M |
| Net Cash Per Share | $0.30 |
| Equity (Book Value) | 382,380 |
| Book Value Per Share | -0.04 |
| Working Capital | -14.51M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $19.48 million and capital expenditures -$1.59 million, giving a free cash flow of $17.89 million.
| Operating Cash Flow | 19.48M |
| Capital Expenditures | -1.59M |
| Free Cash Flow | 17.89M |
| FCF Per Share | $0.38 |
Full Cash Flow StatementMargins
Gross margin is 87.57%, with operating and profit margins of -0.83% and -2.41%.
| Gross Margin | 87.57% |
| Operating Margin | -0.83% |
| Pretax Margin | -1.83% |
| Profit Margin | -2.41% |
| EBITDA Margin | -0.15% |
| EBIT Margin | -0.83% |
| FCF Margin | 7.28% |
Dividends & Yields
LifeMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.19% |
| Shareholder Yield | -13.19% |
| Earnings Yield | -2.77% |
| FCF Yield | 5.48% |
Analyst Forecast
The average price target for LifeMD is $12.50, which is 81.42% higher than the current price. The consensus rating is "Buy".
| Price Target | $12.50 |
| Price Target Difference | 81.42% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 14, 2020. It was a reverse split with a ratio of 1:5.
| Last Split Date | Oct 14, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:5 |
Scores
LifeMD has an Altman Z-Score of 0.82 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.82 |
| Piotroski F-Score | 3 |